Literature DB >> 22863756

The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: pidotimod(PTD).

Xiaofang Hu1, Wei Zhang, Lu Wang, Nan Wan, Bing Wang, Weiwei Li, Hui Hua, Xu Hu, Fengping Shan.   

Abstract

The aim of present research is to analyze the detailed changes of dendritic cells (DCs) induced by pidotimod(PTD). These impacts on DCs of both bone marrow derived DCs and established DC2.4 cell line were assessed with use of conventional scanning electron microscopy (SEM), flow cytometry (FCM), transmission electron microscopy (TEM), cytochemistry assay FITC-dextran, bio-assay and enzyme linked immunosorbent assay (ELISA). We demonstrated the ability of PTD to induce DC phynotypic and functional maturation as evidenced by higher expression of key surface molecules such as MHC II, CD80 and CD86. The functional tests proved the downregulation of ACP inside the DCs, occurred when phagocytosis of DCs decreased, with simultaneously antigen presentation increased toward maturation. Finally, PTD also stimulated production of more cytokine IL-12 and less TNF-α. Therefore it is concluded that PTD can markedly exert positive induction to murine DCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863756      PMCID: PMC3579906          DOI: 10.4161/hv.20579

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  31 in total

1.  [Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency].

Authors:  Alain R Rodríguez Orozco
Journal:  Rev Alerg Mex       Date:  2003 Sep-Oct

2.  Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study.

Authors:  A Auteri; A L Pasqui; F Bruni; M Saletti; M Di Renzo; G Bova
Journal:  Pharmacol Res       Date:  1992-09       Impact factor: 7.658

3.  Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children.

Authors:  Dimitrios Gourgiotis; Nikolaos G Papadopoulos; Apostolos Bossios; Petros Zamanis; Photini Saxoni-Papageorgiou
Journal:  J Asthma       Date:  2004       Impact factor: 2.515

4.  Pidotimod in the management of vulvar papillomatosis: double-blind clinical trial versus placebo.

Authors:  B Guerra; A Perino; F Polatti; M Scala
Journal:  Am J Ther       Date:  1998-05       Impact factor: 2.688

5.  Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK).

Authors:  Jinling Liu; Jingling Liu; Wenna Chen; Jingjuan Meng; Changlong Lu; Enhua Wang; Fengping Shan
Journal:  Cancer Immunol Immunother       Date:  2012-03-06       Impact factor: 6.968

6.  In vivo antiviral effects of pidotimod.

Authors:  C Dianzani; D Colangelo; E Tonso; S Guidotto; I Viano
Journal:  Arzneimittelforschung       Date:  1994-12

7.  Modulating effects of the synthetic thymic dipeptide pidotimod on the immune system in the aging rat.

Authors:  A Chiarenza; M P Iurato; N Barbera; L Lempereur; G Cantarella; U Scapagnini; R Bernardini
Journal:  Pharmacol Toxicol       Date:  1994 Apr-May

8.  Effects of pidotimod on macrophage functions in methylprednisolone-treated mice.

Authors:  D Taramelli; M G Malabarba; N Basilico; G Sala; R Mattina; C Cocuzza
Journal:  Arzneimittelforschung       Date:  1994-12

9.  Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator Pidotimod.

Authors:  R di Marco; F Condorelli; R Girardello; C Uslenghi; G Chisari; M di Mauro; A M Speciale; P L Meroni; F Nicoletti
Journal:  Scand J Infect Dis       Date:  1992

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  2 in total

1.  Rho-Associated Kinase Inhibitors Promote Microglial Uptake Via the ERK Signaling Pathway.

Authors:  Peicai Fu; Ronghua Tang; Zhiyuan Yu; Caihong Li; Xue Chen; Minjie Xie; Wei Wang; Xiang Luo
Journal:  Neurosci Bull       Date:  2016-01-18       Impact factor: 5.203

2.  Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence.

Authors:  Susanna Esposito; Manuel E Soto-Martinez; Wojciech Feleszko; Marcus H Jones; Kun-Ling Shen; Urs B Schaad
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.